A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus

NCT03018938 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

814

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin Analog Mid Mixture
DRUG: Basal Insulin Analog

Sponsor

Eli Lilly and Company